Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The aging population
- A useful definition of aging
- A bizarrely underappreciated truth
- ARDs and aging: conventional view
- ARDs and aging: correct view
- How age-related disease is addressed today
- Targeting pathology: tricky
- Targeting metabolism: also tricky
- Maintenance: targeting damage
- Categorizing damage
- Aging of mitotic cells (1)
- Aging of mitotic cells (2)
- Aging of mitotic cells: cell loss, cell atrophy
- Aging of blood stem cells
- Aging of peripheral blood
- Uncompensated cell loss
- Aging of mitotic cells: division-obsessed cells
- Cancer: it’s part of aging
- Aging of mitotic cells: death-resistant cells
- Cell senescence
- Aging of mitotic cells: mitochondrial mutations
- A mysterious dichotomy
- Addressing each category
- Spontaneous, induced regeneration
- Transplantation – of what?
- Addressing each category
- Cancer’s only universal weakness?
- Maintenance approach: death-resistant cells
- A particularly clean POC
- Maintenance approach: mitochondrial mutations
- Reinforcement rather than repair
- Concluding remarks
Topics Covered
- Aging
- Types of mitotic cell aging
- Aging of blood cells in marrow and circulation
- Cell senescence
- Mitochondrial mutations
- Stem cell therapy
- Tissue engineering
- Suicide gene therapy
- Telomere length control
- Allotopic expression
Talk Citation
de Grey, A. (2014, March 5). The aging of mitotic cells: regeneration and aging [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/FQDW3548.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Aubrey de Grey has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Cell Biology
Transcript
Please wait while the transcript is being prepared...
0:00
Today, I will be discussing
the aging of mitotic cells.
This includes cells which divide
throughout life regularly.
So in other words,
mitotically active cells.
And also cells which only
divide when subjected
to some stimulus,
mitotically competent cell.
Cells which I will not
be discussing today
are ones which are post-mitotic.
In other words, cells that have
differentiated into a form that
is constitutively incapable
of further division,
such as neurons, muscle
fibers, for example.
Also, today, I shall be discussing
a potential to rejuvenate cells that
are mitotically competent
or mitotically active.
In other words, to
restore their function
and/or their number
in the body to a state
that resembles what
exists in young adults.
This can be called
regenerative medicine.
As you will see, in
many cases, it goes
beyond the conventional definitions
of regenerative medicine.
1:05
We all know that aging is a major
problem, whether economically,
or in the humanitarian sense,
or in any sense we like really.
On this slide I am
simply showing the change
in the demographic situation
that has occurred since 1950
and is projected through 2050.
Here we are talking
about the US population.
But, of course, the
situation is very
similar throughout the
industrialized world.
And it's getting that way
in the rest of the world.
The proportion of the population
that is over 65 is growing.
Now, of course, other
things being equal,
that is something to celebrate.
It is always a good
thing to preserve life.
But this is also a great problem
because, as things stand,
we do not have the medical capacity
to maintain the health of people
as they get progressively
beyond that.
And my work, and the work
of SENS Research Foundation,
and indeed the work of an
increasing number of biologists
around the world, is geared
towards changing that,
so that people can stay
healthy as long as they live.
There will actually be,
potentially, quite a big side
effect of that in terms
of how long people live.
But we must always remember that
the longevity of any individual
or the average longevity
of the population
is a cause for celebration.
The longer we can have
people live the better,
because life is valuable.
And, therefore, the goal is to
improve the quality of that life.
And any quantity of that life
that may increase is a bonus.